Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model
- 21 December 2011
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 341 (1), 2-15
- https://doi.org/10.1124/jpet.111.187112
Abstract
Kinetic parameters describing hepatic uptake in hepatocytes are frequently estimated without appropriate incorporation of bidirectional passive diffusion, intracellular binding, and metabolism. A mechanistic two-compartment model was developed to describe all of the processes occurring during the in vitro uptake experiments performed in freshly isolated rat hepatocytes plated for 2 h. Uptake of rosuvastatin, pravastatin, pitavastatin, valsartan, bosentan, telmisartan, and repaglinide was investigated over a 0.1 to 300 μM concentration range at 37°C for 2 or 45–90 min; nonspecific binding was taken into account. All concentration-time points were analyzed simultaneously by using a mechanistic two-compartment model describing uptake kinetics [unbound affinity constant (Km,u), maximum uptake rate (Vmax), unbound active uptake clearance (CLactive,u)], passive diffusion [unbound passive diffusion clearance (Pdiff,u)], and intracellular binding [intracellular unbound fraction (fucell)]. When required (telmisartan and repaglinide), the model was extended to account for the metabolism [unbound metabolic clearance (CLmet,u)]. The CLactive,u ranged 8-fold, reflecting a 11-fold range in uptake Km,u, with telmisartan and valsartan showing the highest affinity for uptake transporters (Km,u 70% of total uptake for all drugs investigated and was 4- and 112-fold greater than CLmet,u for telmisartan and repaglinide, respectively. Modeling of uptake kinetics in conjunction with metabolism improved the precision of the uptake parameter estimates for repaglinide and telmisartan. Recommendations are made for uptake experimental design and modeling strategies.Keywords
This publication has 42 references indexed in Scilit:
- Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported DrugsDrug Metabolism and Disposition, 2011
- Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytesChemico-Biological Interactions, 2011
- Repaglinide‐gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanismBritish Journal of Clinical Pharmacology, 2010
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Design, Data Analysis, and Simulation of in Vitro Drug Transport Kinetic Experiments Using a Mechanistic in Vitro ModelDrug Metabolism and Disposition, 2008
- SLCO1B1 variants and statin-induced myopathy - A genomewide studyNew England Journal of Medicine, 2008
- Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat HepatocytesPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- In vitro-in vivo extrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspectsXenobiotica, 2007
- DAISY: A new software tool to test global identifiability of biological and physiological systemsComputer Methods and Programs in Biomedicine, 2007
- Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatinXenobiotica, 2003